Surgical management of Encapsulating Peritoneal Sclerosis (EPS) in children: international case series and literature review.

Videha Sharma, Zia Moinuddin, Angela Summers, Mohan Shenoy, Nicholas Plant, Semir Vranic, Agnieszka Prytula, Zlatan Zvizdic, Vasiliki Karava, Nikoleta Printza, John Vlot, David van Dellen, Titus Augustine

Journal: Pediatric nephrology (Berlin, Germany) 2022;37(3):643-650

PMID: 34448023

Abstract

BACKGROUND

Encapsulating Peritoneal Sclerosis (EPS) is a rare phenomenon in paediatric patients with kidney failure treated with peritoneal dialysis (PD). This study highlights clinical challenges in the management of EPS, with particular emphasis on peri-operative considerations and surgical technique.

METHODS

Retrospective analysis of all paediatric patients with EPS treated at the Manchester Centre for Transplantation.

RESULTS

Four patients were included with a median duration of 78 months on PD. All patients had recurrent peritonitis (> 3 episodes), and all had symptoms within three months of a change of dialysis modality from PD to haemodialysis or transplant. In Manchester, care was delivered by a multi-disciplinary team, including surgeons delivering the adult EPS surgical service with a particular focus on nutritional optimisation, sepsis control, and wound management. The surgery involved laparotomy, lavage, and enterolysis of the small bowel + / - stoma formation, depending on intra-abdominal contamination. Two patients had a formal stoma, which were reversed at three and six months, respectively. Two patients underwent primary closure of the abdomen, whereas two patients had re-look procedures at 48 h with secondary closure. One patient had a post-operative wound infection, which was managed medically. One patient's stoma became detached, leading to an intra-abdominal collection requiring re-laparotomy. The median length of stay was 25 days, and patients were discharged once enteral feeding was established. All patients remained free of recurrence with normal gut function and currently two out of four have functioning transplants.

CONCLUSIONS

This series demonstrates 100% survival and parenteral feed independence following EPS surgery. Post-operative morbidity was common; however, with individualised experience-based decision-making and relevant additional interventions, patients made full recoveries. Health and development post-surgery continued, allowing the potential for transplantation. A higher resolution version of the Graphical abstract is available as Supplementary information.

© 2021. The Author(s).

Address: Department of Renal and Pancreas Transplantation, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Oxford Road, Manchester, M13 9WL, UK. [email protected].; Department of Renal and Pancreas Transplantation, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Oxford Road, Manchester, M13 9WL, UK.; Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.; College of Medicine, QU Health, Qatar University, Doha, Qatar.; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.; Paediatric Nephrology and Rheumatology Department, Ghent University Hospital, Ghent, Belgium.; Clinical Centre University of Sarajevo, Sarajevo, Bosnia and Herzegovina.; Aristotle University of Thessaloniki, Thessaloniki, Greece.; Sophia Children's Hospital, Erasmus MC: University Medical Centre, Rotterdam, The Netherlands.; Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Manchester, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.